Issue 4269. Last Updated: 11/07/2009

Cancer Drug Spurned in U.S. Approved

Bloomberg
Antigenics, the maker of a drug that stimulates the immune system against kidney cancer, won approval to market the product in Russia after a study failed to meet the statistical standard in the United States.

Subscribing to The Moscow Times online

To receive access to this service, you will have to register and subscribe.

If you have any difficulties with making payment please contact Yury Voloshin at payment@themoscowtimes.com



Discussion

Comments

print


 For bloggers



Most Read

  1. Very Little to Celebrate
  2. Putin Lashes Out at GM on Opel Sale
  3. Spymaster Warns of Georgian Attack
  4. Yandex to Close List That Annoyed State
  5. Spy With ‘Twisted Biography’ Is Laid to Rest
  6. Markelov Killing Linked to Revenge
  7. Russia Pitches Debt in London
  8. Tbilisi Fights Back With Russian TV Channel
  9. Spending Money Hand Over Fist
  10. Gas Glut May Affect Russia